Patents by Inventor Jong-su YOO

Jong-su YOO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR AMELIORATING OR TREATING DEMENTIA CONTAINING 2'-FUCOSYLLACTOSE
    Publication number: 20240173341
    Abstract: Disclosed is a method for, preventing, ameliorating or treating dementia by administering a composition containing 2?-fucosyllactose. 2?-FL ameliorates brain damage caused by amyloid beta and neuroinflammation by suppressing or preventing accumulation of the amyloid beta, thus being highly effective in preventing, ameliorating and treating dementia.
    Type: Application
    Filed: November 14, 2023
    Publication date: May 30, 2024
    Applicant: Advanced Protein Technologies Corp.
    Inventors: Chul Soo SHIN, Jong Won YOON, Seon Min JEON, Young Ha SONG, Jong Gil YOO, Jeong Su BANG
  • METHOD FOR INCREASING PRODUCTIVITY OF 2'-FUCOSYLLACTOSE THROUGH CHANGES IN CULTURE MEDIUM COMPOSITION AND CULTURING
    Publication number: 20240093254
    Abstract: The present invention relates to a method for increasing the productivity of 2?-fucosyllactose through various changes in culture medium composition and culturing on the basis of lactose, which is a substrate, wherein 2-fucosyllactose can be continuously produced in a high-yield at an optimum lactose concentration discovered by a culturing method of the present invention.
    Type: Application
    Filed: October 31, 2022
    Publication date: March 21, 2024
    Applicants: Advanced Protein Technologies Corp., SEOUL NATIONAL UNIVERSITY R&DB FORNDATION
    Inventors: Chul Soo SHIN, Jong Won YOON, Young Ha SONG, Young Sun YOO, Jeong Su BANG, Heon Hak LEE
  • RIVASTIGMINE PATCH FOR LONG-TERM ADMINISTRATION
    Publication number: 20210330630
    Abstract: The present invention relates to a patch comprising a high content of rivastigmine per unit area, which can be continuously administered for a long time. The rivastigmine patch according to the present invention is capable of continuous release of rivastigmine for a long period of time, preferably 3 days, more preferably 4 days or more after attachment, and has excellent physical and chemical stability.
    Type: Application
    Filed: August 30, 2019
    Publication date: October 28, 2021
    Inventors: Namho KIM, Wonjae CHOI, Hunseung YOO, Soo Min LEE, Yeo-Jin PARK, Sung-Hyuk KIM, Jong-su YOO, Young-me LEE
  • RIVASTIGMINE PATCH FOR LONG-TERM ADMINISTRATION
    Publication number: 20210330602
    Abstract: The present invention relates to a patch comprising a high content of rivastigmine per unit area, which can be continuously administered for a long time. The rivastigmine patch according to the present invention is capable of continuous release of rivastigmine for a long period of time, preferably 3 days, more preferably 4 days or more after attachment, and has excellent physical and chemical stability.
    Type: Application
    Filed: August 30, 2019
    Publication date: October 28, 2021
    Inventors: Namho KIM, Wonjae CHOI, Hunseung YOO, Soo Min LEE, Yeo-Jin PARK, Sung-Hyuk KIM, Jong-su YOO, Young-me LEE